Matches in Wikidata for { <http://www.wikidata.org/entity/Q56899094> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- Q56899094 description "article by Brian I Rini et al published 15 February 2011 in Cancer" @default.
- Q56899094 description "im Februar 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q56899094 description "wetenschappelijk artikel" @default.
- Q56899094 description "наукова стаття, опублікована в лютому 2011" @default.
- Q56899094 name "Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma" @default.
- Q56899094 name "Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma" @default.
- Q56899094 type Item @default.
- Q56899094 label "Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma" @default.
- Q56899094 label "Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma" @default.
- Q56899094 prefLabel "Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma" @default.
- Q56899094 prefLabel "Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma" @default.
- Q56899094 P1433 Q56899094-BC044A8B-E3EA-42D9-AD77-82655473E17E @default.
- Q56899094 P1476 Q56899094-45FAB973-9EDF-49E3-BCB2-5F1A7B6F205D @default.
- Q56899094 P2093 Q56899094-00BB069F-69F8-40EF-8392-50FC1161F401 @default.
- Q56899094 P2093 Q56899094-07D42E11-542C-4DB2-847E-0C72E58E0B56 @default.
- Q56899094 P2093 Q56899094-1A3753C5-D370-465B-8BBF-A5FCC723A3BC @default.
- Q56899094 P2093 Q56899094-2F48C0C4-BC73-4D3B-B4C0-565C8DE09DCC @default.
- Q56899094 P2093 Q56899094-4FAEA20F-1F8A-4D58-BA84-B8C6E73FF6AE @default.
- Q56899094 P2093 Q56899094-D780467F-21D8-470F-854D-6ACB4534C657 @default.
- Q56899094 P2093 Q56899094-F64F445F-2E33-4254-BD56-3F6202552960 @default.
- Q56899094 P2093 Q56899094-FB42DD3E-C52A-4C75-BEDE-8FA60753E796 @default.
- Q56899094 P2093 Q56899094-FD0C3BED-1101-4349-8CA5-A7BC04801E74 @default.
- Q56899094 P2093 Q56899094-FD25EB82-A301-4849-8700-FED0F9B2AC03 @default.
- Q56899094 P2860 Q56899094-20F83F85-3CA6-43B8-99F2-55DDBA087308 @default.
- Q56899094 P2860 Q56899094-36AEC087-684A-4146-8BD1-452A1A2CF5B0 @default.
- Q56899094 P2860 Q56899094-3B95735D-8EE0-4983-BC2B-FDCC1882A626 @default.
- Q56899094 P2860 Q56899094-47E64663-A064-4B15-B1E2-4B26056DE02A @default.
- Q56899094 P2860 Q56899094-694E63F3-2FC0-40FD-83F6-F089D7D06B0D @default.
- Q56899094 P2860 Q56899094-AB780149-1A8B-4EE7-B28F-B042CC88F476 @default.
- Q56899094 P2860 Q56899094-BC0FFBAF-76B6-45A5-A746-3F88A48B3C9D @default.
- Q56899094 P2860 Q56899094-CF9E27D8-29DD-4244-A025-3B3468F15C88 @default.
- Q56899094 P2860 Q56899094-EDC4F3A8-D10D-4A59-90BF-135E88BDB849 @default.
- Q56899094 P2860 Q56899094-FFEB7B21-8241-4A21-8EFC-37972992D3D5 @default.
- Q56899094 P304 Q56899094-7B0F7786-17F0-4DA1-B06D-6025B9DF0469 @default.
- Q56899094 P31 Q56899094-EBDA8579-1215-46AA-96D1-992098FE6B30 @default.
- Q56899094 P356 Q56899094-BDCB3388-5939-4970-80EA-E7D30B52079E @default.
- Q56899094 P407 Q56899094-BA4DC463-BCB1-4C92-A13F-4A33444B70DC @default.
- Q56899094 P433 Q56899094-DACCC133-D4C4-4C14-A8F9-205A70727C28 @default.
- Q56899094 P478 Q56899094-8FD3BD79-21B7-419A-B468-F99B6694C999 @default.
- Q56899094 P577 Q56899094-810D1AD7-BAE2-4138-8723-6A82DAF61B4E @default.
- Q56899094 P698 Q56899094-A0371A01-AB69-4346-B6B4-5E4C6B8D1943 @default.
- Q56899094 P921 Q56899094-00F56B1B-9FD4-46EB-9C14-09E09A2A7D2C @default.
- Q56899094 P921 Q56899094-424BF362-E0F0-4BD7-A71F-0E618DC02660 @default.
- Q56899094 P921 Q56899094-B7BECBFF-36A4-444B-B3C4-FEA059E3FDCF @default.
- Q56899094 P921 Q56899094-EA1BF134-8ED8-4B76-A37F-93B90CFA3EB1 @default.
- Q56899094 P356 CNCR.25639 @default.
- Q56899094 P698 20922784 @default.
- Q56899094 P1433 Q326041 @default.
- Q56899094 P1476 "Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma" @default.
- Q56899094 P2093 "Allison Tyler" @default.
- Q56899094 P2093 "Bo Huang" @default.
- Q56899094 P2093 "Brian I Rini" @default.
- Q56899094 P2093 "Diane Healey" @default.
- Q56899094 P2093 "Joe J Stephenson" @default.
- Q56899094 P2093 "Lorie Catlett" @default.
- Q56899094 P2093 "Mark Stein" @default.
- Q56899094 P2093 "Michael Gordon" @default.
- Q56899094 P2093 "Pat Shannon" @default.
- Q56899094 P2093 "Simantini Eddy" @default.
- Q56899094 P2860 Q28282757 @default.
- Q56899094 P2860 Q33369361 @default.
- Q56899094 P2860 Q36773296 @default.
- Q56899094 P2860 Q37641505 @default.
- Q56899094 P2860 Q43299262 @default.
- Q56899094 P2860 Q46093084 @default.
- Q56899094 P2860 Q46106546 @default.
- Q56899094 P2860 Q46312545 @default.
- Q56899094 P2860 Q56900159 @default.
- Q56899094 P2860 Q71607047 @default.
- Q56899094 P304 "758-67" @default.
- Q56899094 P31 Q13442814 @default.
- Q56899094 P356 "10.1002/CNCR.25639" @default.
- Q56899094 P407 Q1860 @default.
- Q56899094 P433 "4" @default.
- Q56899094 P478 "117" @default.
- Q56899094 P577 "2011-02-15T00:00:00Z" @default.
- Q56899094 P698 "20922784" @default.
- Q56899094 P921 Q1164529 @default.
- Q56899094 P921 Q181600 @default.
- Q56899094 P921 Q19000948 @default.
- Q56899094 P921 Q5452194 @default.